Shipping Challenges: Kedrion's Vital Deliveries Through Hormuz

Italian biopharmaceutical giant Kedrion is encountering potential issues delivering vital plasma-based medicines to Iranian patients, as shipping through the crucial Strait of Hormuz may be disrupted.

In an interview with Reuters, CEO Ugo Di Francesco disclosed that the company is adapting by using land routes to transport immunoglobulins to Iran. This adjustment is necessary due to escalating fuel prices, which threaten to make logistics prohibitively expensive.

'It's a question of logistics, namely our ability to physically deliver products to patients,' Di Francesco stated. Despite the challenges, the company reported no significant impact on its ability to provide life-saving treatments yet.